𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia

✍ Scribed by Rex W. Bolin; William A. Robinson; Jeff Sutherland; Dr. Richard F. Hamman

Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
311 KB
Volume
50
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Morphological and functional characteris
Morphological and functional characteristics of short-term and long-term bone marrow cultures in chronic myelogenous leukemia
✍ Budak-Alpdo?an, TοΏ½lin; Alpdo?an, οΏ½nder; Ako?lu, Tevfik πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 357 KB πŸ‘ 1 views

Clonogenic capacity of bone marrow progenitors and stromal layers established from bone marrow of 12 patients with CML and 13 healthy controls were evaluated. The initial BFU-E and CFU-GM contents were slightly higher in the CML patients (p > 0.05) in contrast to CFU-GEMM. CFU-GEMM was lower in the

Hydroxyurea-Induced gangrene of the toes
Hydroxyurea-Induced gangrene of the toes in a patient with chronic myelogenous leukemia
✍ Yasuda, Norimasa; Ohmori, Sei-ichi; Usui, Tadao πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 148 KB πŸ‘ 2 views

To the Editor: Semenzato et al. proposed new criteria for large granular lymphocyte (LGL) leukemia because patients with low levels of GL were similar to those with levels greater than 2,000 GL/l [1]. LGL leukemia is a GL proliferative disease often accompanied by pure red cell aplasia (PRCA). T-cel

Long-term response in accelerated-phase
Long-term response in accelerated-phase chronic myelogenous leukemia with protracted splenic irradiation and ?-interferon
✍ Girinsky, T.; Bonomi, M.; Bayle, C. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 40 KB πŸ‘ 1 views

Forming Assay From CD34 + Bone Marrow Cells Serum a BFU-E/10 2 CD34 + cells Control 1 50.2 Β± 4.6 Control 2 48.5 Β± 14.1 Before chemotherapy 24.4 Β± 6.2 b After chemotherapy 50.5 Β± 6.5 Values are means Β± SD of triplicate cultures. a Control 1; normal AB serum, Control 2; serum from a patient with AILD-